VMD: Report on Corporate Governance for the first half of 2026
Filed with HOSE · · 36 pages · English and French
Vimedimex Medi-Pharma JSC on 6ix
Earlier from Vimedimex Medi-Pharma JSC
- VMD: Decision on changing from supervision to trading restriction status
- VMD: Announcement of the status of VMD shares
- VMD: Report on the progress of the remediation of the status of controlled securities
- VMD: Reminder of information disclosure
- VMD: Explanation of the differences in profit after tax in the first six months of 2026
Later from Vimedimex Medi-Pharma JSC
- VMD: Report on Corporate Governance 2025
- VMD: Annual Report 2025
- VMD: Information related to the 2025 cash dividend payment
Follow Vimedimex Medi-Pharma JSC into a list and get an email when it puts out news.
Follow Vimedimex Medi-Pharma JSC